Vivaldi Capital Management LP
Source: SEC Form 13F · as of Mar 2026Vivaldi Capital Management LP holds 16 biotech & pharma companies tracked by BioSniper, totaling $39.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$39.4M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 46,681 | $16.4M |
| LLYELI LILLY & Co | 9,656 | $8.9M |
| ZBHZimmer Biomet Holdings Inc. | 63,540 | $5.7M |
| HALOHALOZYME THERAPEUTICS, INC. | 24,499 | $1.6M |
| ABBVAbbVie Inc. | 6,830 | $1.5M |
| JNJJOHNSON & JOHNSON | 3,243 | $793K |
| GALTGALECTIN THERAPEUTICS INC | 258,584 | $721K |
| ABTABBOTT LABORATORIES | 6,930 | $712K |
| MRKMerck & Co., Inc. | 5,197 | $625K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,209 | $598K |
| LENZLENZ Therapeutics, Inc. | 64,052 | $586K |
| PMPhilip Morris International Inc | 2,237 | $370K |
| URGNUroGen Pharma Ltd. | 15,661 | $282K |
| MCKMcKesson Corporation | 272 | $235K |
| PFEPFIZER INC | 8,331 | $234K |
| KRMDKORU Medical Systems Inc. Common Stock (DE) | 29,885 | $129K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.